Bruker faced a tough 2024, with aggressive M&A, $600M preferred issuance, rising debt, and execution issues prompting a ...

Vertex Pharmaceuticals dominates the cystic fibrosis treatment market and recently has expanded into other therapeutic areas. The biotech predicts full-year 2025 revenue of as much as $12 billion.

The standard advice is to hold off, but most retirees claim the benefit as soon as they can, at age 62. Here’s what to know when you’re planning the unplannable. Blair Barondes and his wife, Janet ...